pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,524 catalysts · 6,181 phase readout · 2,337 8k filing · 395 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 118 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout6,181
  • 8k filing2,337
  • earnings395
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›NOT_YET_RECRUITINGphase readoutNCT07633873: SYS6010 Combined With Enlonstobart Versus Immunotherapy+ Platinum-based Chemotherapy for Patients With PD-L1-Positive Locally Advanced or Metastatic NSCLC(SYNSTAR 04)

Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd.. Phase: PHASE3. Conditions: Non-Small Cell Lung Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06388941: Iptacopan in Patients With ANCA Associated Vasculitis

Sponsor: Novartis Pharmaceuticals. Phase: PHASE2. Conditions: Anti-Neutrophil Cytoplasm Antibodies (ANCA) Associated Vasculitis

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07560241: The Effects of an Intermodal Art Therapy Program on Depression, Anxiety, Stress, and Emotion Regulation Skill Levels in Nursing Students: A Randomized Controlled Study

Sponsor: Atlas University. Phase: NA. Conditions: Art Therapy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07406854: A Phase 3, Multicenter, Randomized, Double-Masked, Sham-Controlled Clinical Trial for Leber's Hereditary Optic Neuropathy (LHON) Associated With ND4 Mutation

Sponsor: Wuhan Neurophth Biotechnology Limited Company. Phase: PHASE3. Conditions: Leber Hereditary Optic Neuropathy (LHON)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07345754: Women Supporting Women to Improve Infant and Child Feeding Practices in Pakistan

Sponsor: University of British Columbia. Phase: NA. Conditions: Malnutrition in Children

full page →ctgov ↗
›RECRUITINGphase readoutNCT07342205: A Study on the Treatment of Patients With Acute Lung Injury Caused by Sepsis Through Microbiota Transplantation

Sponsor: Shanghai University of Traditional Chinese Medicine. Phase: PHASE2. Conditions: Acute Respiratory Distress Syndrome (ARDS), Acute Lung Injury(ALI), Sepsis Related Acute Lung Injury/Acute Respiratory Distress Syndrome

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03654105: Screening and Multiple Intervention on Lung Epidemics

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano. Phase: PHASE2. Conditions: Inflammation, Smoking Cessation, Diet Modification, Physical Activity, Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT04883905: ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)

Sponsor: Alnylam Pharmaceuticals. Phase: . Conditions: Acute Hepatic Porphyria

full page →ctgov ↗
›RECRUITINGphase readoutNCT07660094: Aglatimagene Besadenovec + Prodrug and Pembrolizumab vs Docetaxel for Stage IV Non-Squamous NSCLC Progressing on Pembrolizumab (AURORA)

Sponsor: Candel Therapeutics, Inc.. Phase: PHASE3. Conditions: Non-squamous, Non-Small Cell Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT05278494: Dextromethorphan for Treatment of Postoperative Pain

Sponsor: Nathanael Heckmann. Phase: NA. Conditions: Post-operative Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT07329166: Reducing Mobility-associated Interruption in HIV Treatment in Malawi

Sponsor: University of California, Los Angeles. Phase: NA. Conditions: HIV

full page →ctgov ↗
›COMPLETEDphase readoutNCT05776966: Women's Opioid Treatment Follow-up Study

Sponsor: Mclean Hospital. Phase: NA. Conditions: Opioid Use Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT07185256: Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)

Sponsor: Opus Genetics, Inc. Phase: PHASE1. Conditions: ARB, BVMD, Autosomal-Dominant Bestrophinopathy, Best Vitelliform Macular Dystrophy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07440056: Physical Inactivity Among Patients With Cardiovascular Risk

Sponsor: University of Colombo. Phase: NA. Conditions: Physical Activities, Cardiovascular (CV) Risk, Empowerment

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04729322: Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Metastatic Colorectal Adenocarcinoma, Metastatic Small Intestinal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8, Stage IV Small Intestinal Adenocarcinoma AJCC v8, Stage IVA Colorectal Cancer AJCC v8, Stage IVB Colorectal Cancer AJCC v8, Stage IVC Colorectal Cancer AJCC v8

full page →ctgov ↗
›RECRUITINGphase readoutNCT07216053: Predictive Value of Lung Ultrasound for Respiratory Decompensation in Late Preterm Neonates

Sponsor: Hackensack Meridian Health. Phase: . Conditions: Pre-Term, Respiratory Distress of Newborn, Premature

full page →ctgov ↗
›RECRUITINGphase readoutNCT07039253: Pilot Trial of Clinic-based Dating Violence Prevention Program for Adolescents and Caregivers

Sponsor: University of Pittsburgh. Phase: NA. Conditions: Dating Violence, Parent, Primary Care

full page →ctgov ↗
›RECRUITINGphase readoutNCT06112353: Neuromuscular Blockade Comparison for GI-2 Recovery After Bowel Resection

Sponsor: University of California, Irvine. Phase: PHASE4. Conditions: Intestinal Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT01269853: Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA

Sponsor: Northwell Health. Phase: PHASE1. Conditions: Glioblastoma Multiforme, Anaplastic Astrocytoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07323745: Long-Term Effects of Mobithron Advance on Knee Osteoarthritis Aims to Investigate the Effects of Mobithron Advance on OA Progression

Sponsor: Universiti Sains Malaysia. Phase: EARLY_PHASE1. Conditions: Osteoarthritis (OA) of the Knee

full page →ctgov ↗
›COMPLETEDphase readoutNCT06624072: A Study in Healthy People to Compare 2 Different Formulations of Nerandomilast Tablets When Taken With or Without Food

Sponsor: Boehringer Ingelheim. Phase: PHASE1. Conditions: Healthy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07578272: Prevention of Medical, Social, and Psychosocial Risks Following a Parkinson's Disease Diagnosis: A Pilot Study

Sponsor: University Hospital, Toulouse. Phase: NA. Conditions: Parkinson Disease

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07758595: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL921 in Healthy Participants and Participants With Alzheimer's Disease

Sponsor: Denali Therapeutics Inc.. Phase: PHASE1. Conditions: Alzheimer's Disease, Healthy Participants

full page →ctgov ↗
›COMPLETEDphase readoutNCT04981795: realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL

Sponsor: Incyte Corporation. Phase: . Conditions: Diffuse Large B-cell Lymphoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07559877: Topical Chlorhexidine Spray for the Prevention of Acute Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma:

Sponsor: Jiangxi Provincial Cancer Hospital. Phase: PHASE3. Conditions: Nasopharangeal Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07754877: Safety and Efficacy of Microwave Ablation Alone Versus Microwave Ablation Combined With Chemical Ablation in the Treatment of Uterine Fibroids: A Prospective, Multicenter Study

Sponsor: Peking University Aerospace Center Hospital. Phase: NA. Conditions: Uterine Fibroids (UF), Microwave Ablation, Ultrasound

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06867601: Work-related Challenges in Psychiatric-psychosomatic Clinics

Sponsor: Jacobs University Bremen gGmbH. Phase: . Conditions: Work Engagement, Burnout, Job Satisfaction, Turnoverintention, Service Quality

full page →ctgov ↗
›RECRUITINGphase readoutNCT03819101: Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris. Phase: PHASE3. Conditions: Prostate Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07609875: A Phase I Single and Multiple Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of HS-10522 in Healthy Chinese Participants and Chinese Participants With Mild Hypertension

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Healthy Adult, Hypertension

full page →ctgov ↗
›RECRUITINGphase readoutNCT07329075: Soft Robot for Rehabilitation of Hand Function After Stroke

Sponsor: Chinese University of Hong Kong. Phase: NA. Conditions: Stroke

full page →ctgov ↗
›WITHHELDphase readoutNCT06042101: [Trial of device that is not approved or cleared by the U.S. FDA]

Sponsor: [Redacted]. Phase: . Conditions:

full page →ctgov ↗
›RECRUITINGphase readoutNCT07402512: A Phase III Study of Deuremidevir Hydrobromide for the Treatment of RSV Infection in Infants and Young Children

Sponsor: Simcere Pharmaceutical Co., Ltd. Phase: PHASE3. Conditions: Respiratory Syncytial Virus Infection

full page →ctgov ↗
›WITHDRAWNphase readoutNCT07375212: VAPorized Administration of Bumetanide for Outpatient Relief in Heart Failure

Sponsor: Prisma Health-Upstate. Phase: PHASE4. Conditions: Heart Failure Congestive

full page →ctgov ↗
›SUSPENDEDphase readoutNCT06477003: Multispectral Optoacoustic Tomography in Head and Neck Squamous Cell Cancer

Sponsor: University of Oklahoma. Phase: NA. Conditions: Head and Neck Squamous Cell Carcinoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT05862688: A Cohort Study on Anti-microbial Stewardship in PICU

Sponsor: Children's Hospital of Fudan University. Phase: . Conditions: Infections

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07458542: Effectiveness and Safety of ONUREG (Oral Azacitidine) in Chinese Patients With Acute Myeloid Leukemia

Sponsor: Bristol-Myers Squibb. Phase: . Conditions: Acute Myeloid Leukemia (AML)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06906042: Multimodal Cardiovascular and Hepatic Population Imaging

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France. Phase: . Conditions: Healthy Volunteers, Imaging Evaluation

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT00679042: Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol

Sponsor: CellTrans Inc.. Phase: PHASE3. Conditions: Type 1 Diabetes Mellitus

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07596342: Electrophysiological Analysis of Gamma-Hydroxybutyrate-induced Sleep in Intensive Care Patients

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: PHASE2. Conditions: Sleep Disorder (Disorder), Critical Care

full page →ctgov ↗
›COMPLETEDphase readoutNCT04469686: Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories

Sponsor: Cristcot HCA LLC. Phase: PHASE3. Conditions: Ulcerative Proctitis

full page →ctgov ↗
›COMPLETEDphase readoutNCT06387186: Leucine Enriched Essential Amino Acid Powder as an Add-on to a Classic Ketogenic Diet in Refractory Epilepsy

Sponsor: Elizabeth Anne Thiele. Phase: PHASE1. Conditions: Refractory Epilepsy, Drug Resistant Epilepsy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07489573: Study of Efficacy and Safety of Secukinumab in Chinese Adult Patients With Moderate to Severe Hidradenitis Suppurativa

Sponsor: Novartis Pharmaceuticals. Phase: PHASE4. Conditions: Hidradenitis Suppurativa (HS)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05524883: Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-251 in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping

Sponsor: Dyne Therapeutics. Phase: PHASE1. Conditions: Duchenne Muscular Dystrophy (DMD)

full page →ctgov ↗
›COMPLETEDphase readoutNCT07615569: Robot-assisted Versus Conventional Physical Therapy for Hand in Sub-acute Stroke

Sponsor: Montiha Azeem. Phase: NA. Conditions: Stroke, Spastic Hemiplegia, Upper Limb Motor Impairment

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07416669: Death, Dying, Violence and Aggression as Shown on Medical Television Series.

Sponsor: King's College Hospital NHS Trust. Phase: . Conditions: End of Life Care, Violent Aggressive Behavior, Television Viewing, Media Use

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04430569: Pulmonary Embolism International THrOmbolysis Study-3

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: PHASE3. Conditions: Pulmonary Embolism

full page →ctgov ↗
›RECRUITINGphase readoutNCT05354869: Transvaginal Electrical Stimulation for Myofascial Pelvic Pain

Sponsor: University of California, Los Angeles. Phase: NA. Conditions: Myofascial Pelvic Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT06544083: Early-stage Detection of Liver Cancer by Proteins in Peripheral Blood

Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine. Phase: . Conditions: Hepatocellular Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT02560883: Hairy Cell Leukemia Patient Data Registry

Sponsor: Ohio State University Comprehensive Cancer Center. Phase: . Conditions: Leukemia, Other

full page →ctgov ↗
›COMPLETEDphase readoutNCT07186283: Pharmacokinetic Study of a Novel Cannabidiol (CBD) Formulation in Healthy Volunteers

Sponsor: NW PharmaTech Ltd. Phase: PHASE1. Conditions: PK in Healthy Volunteers

full page →ctgov ↗
← prev
page 167 of 171
next →